ANNE NIFFENEGGER: Open Payments
NPI 1205541042 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 7 payments from 4 companies in 2025. Trend: 2023 $313 · 2024 $367 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Neuronetics, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: COBENFY, Qelbree, NEUROSTAR TMS THERAPY SYSTEM, ABILIFY MAINTENA.
Industry payments across NE — which companies pay providers there.
